FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+12.43%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$27.2B
AUM Growth
+$1.69B
(+6.6%)
Cap. Flow
-$815M
Cap. Flow
% of AUM
-3%
Top 10 Holdings %
Top 10 Hldgs %
35.28%
Holding
550
New
72
Increased
170
Reduced
177
Closed
71
Top Buys
| 1 |
UnitedHealth
UNH
|
$170M |
| 2 |
JPMorgan Chase
JPM
|
$131M |
| 3 |
Qualcomm
QCOM
|
$121M |
| 4 |
Fiserv
FI
|
$110M |
| 5 |
VeriSign
VRSN
|
$110M |
Top Sells
| 1 |
Amazon
AMZN
|
$393M |
| 2 |
Microsoft
MSFT
|
$306M |
| 3 |
Abbott
ABT
|
$163M |
| 4 |
Home Depot
HD
|
$161M |
| 5 |
AGN
Allergan plc
AGN
|
$146M |
Sector Composition
| 1 | Technology | 32.58% |
| 2 | Healthcare | 21.35% |
| 3 | Consumer Discretionary | 13.11% |
| 4 | Financials | 10.29% |
| 5 | Communication Services | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Rocket Pharmaceuticals
RCKT
$355M
| $592K | ﹤0.01% |
+26,000
| New | +$592K |
|
|
FTSV
377
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $591K | ﹤0.01% |
+15,000
| New | +$591K |
|
|
AMED
378
DELISTED
Amedisys
AMED
| $584K | ﹤0.01% |
+3,500
| New | +$584K |
|
379
Qiagen
QGEN
$10.3B
| $573K | ﹤0.01% |
+16,000
| New | +$573K |
|
|
SWAV
380
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $571K | ﹤0.01% |
13,000
+3,000
| +30% | +$132K |
|
381
American Express
AXP
$227B
| $548K | ﹤0.01% |
4,400
| – | – |
|
382
DuPont de Nemours
DD
$32.5B
| $539K | ﹤0.01% |
8,403
| – | – |
|
383
Idexx Laboratories
IDXX
$51.4B
| $524K | ﹤0.01% |
2,006
-25,509
| -93% | -$6.66M |
|
384
Endava
DAVA
$554M
| $522K | ﹤0.01% |
11,209
-9,045
| -45% | -$421K |
|
385
uniQure
QURE
$982M
| $502K | ﹤0.01% |
+7,000
| New | +$502K |
|
386
Protolabs
PRLB
$1.19B
| $498K | ﹤0.01% |
4,907
-2,402
| -33% | -$244K |
|
387
Xylem
XYL
$34.2B
| $483K | ﹤0.01% |
6,134
-3,671
| -37% | -$289K |
|
388
Tetra Tech
TTEK
$9.48B
| $482K | ﹤0.01% |
27,955
-12,220
| -30% | -$211K |
|
389
Woodward
WWD
$14.5B
| $478K | ﹤0.01% |
4,037
-775
| -16% | -$91.8K |
|
|
ALLK
390
DELISTED
Allakos
ALLK
| $477K | ﹤0.01% |
+5,000
| New | +$477K |
|
391
Gossamer Bio
GOSS
$668M
| $469K | ﹤0.01% |
30,000
| – | – |
|
392
Dow Inc
DOW
$17.3B
| $460K | ﹤0.01% |
8,403
| – | – |
|
393
Apellis Pharmaceuticals
APLS
$3.58B
| $459K | ﹤0.01% |
15,000
-16,000
| -52% | -$490K |
|
394
NMI Holdings
NMIH
$3.1B
| $455K | ﹤0.01% |
13,700
-1,600
| -10% | -$53.1K |
|
395
Mesa Laboratories
MLAB
$356M
| $415K | ﹤0.01% |
1,665
+272
| +20% | +$67.8K |
|
396
Personalis
PSNL
$461M
| $400K | ﹤0.01% |
36,732
-79,225
| -68% | -$863K |
|
397
Agilent Technologies
A
$36.5B
| $394K | ﹤0.01% |
4,621
| – | – |
|
|
SILK
398
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $373K | ﹤0.01% |
9,233
+1,233
| +15% | +$49.8K |
|
|
STML
399
DELISTED
Stemline Therapeutics, Inc.
STML
| $372K | ﹤0.01% |
35,000
| – | – |
|
400
Electronic Arts
EA
$42.2B
| $360K | ﹤0.01% |
3,344
| – | – |
|